Scholarlink

Background <p>There are no established guidelines for antibiotic administration to prevent the development of medication related-osteonecrosis of the jaw (MRONJ) after tooth extraction in patients receiving antiresorptive agents (ARAs). Since 2022, the duration of antibiotic administration during extractions in such patients has been intentionally shortened to prevent antimicrobial resistance at our hospitals.</p> Methods <p>This retrospective study involved 160 patients on low-dose bisphosphonates (BPs) requiring tooth extractions between 2019 and 2024 at four Japanese institutions. In 2019–2021, patients received amoxicillin (AMPC) 500&#xa0;mg 1&#xa0;h before and 750&#xa0;mg per day for 2&#xa0;days post-extraction. In 2022–2024, a single 500&#xa0;mg dose of AMPC was administered 1&#xa0;h pre-extraction. Patients were managed with tension-free wound suturing and regular follow-up. The rates of MRONJ development were compared between the two periods.</p> Results <p>MRONJ developed in 3 out of 170 teeth (1.76%) in 2019–2021, and in 2 out of 147 teeth (1.36%) in 2022–2024, with no significant difference (<i>P</i> = 1.000). All MRONJ cases were low-stage (Stage 1) and healed completely within 12–16&#xa0;weeks. Four out of five MRONJ cases (80%) exhibited radiopaque changes around the root. When all teeth in both groups were surveyed, MRONJ development was significantly higher in teeth with such changes compared to those without (4/58 vs. 1/259; <i>P</i> = 0.004).</p> Conclusion <p>A single preoperative dose of AMPC may be sufficient for tooth extractions in patients on low-dose BPs. However, teeth with radiopaque changes around the root require careful monitoring postextraction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

What is the appropriate antibiotic administration to prevent MRONJ development after tooth extraction?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月2日

查看全文
  • Eiji Iwata,
  • Hiroaki Ohori,
  • Yuriko Susukida,
  • Nanae Yatagai,
  • Masahiko Kashin,
  • Taiki Matsui,
  • Naoki Takata,
  • Masaki Kobayashi,
  • Daisuke Miyai,
  • Akira Tachibana,
  • Masaya Akashi

摘要

Background

There are no established guidelines for antibiotic administration to prevent the development of medication related-osteonecrosis of the jaw (MRONJ) after tooth extraction in patients receiving antiresorptive agents (ARAs). Since 2022, the duration of antibiotic administration during extractions in such patients has been intentionally shortened to prevent antimicrobial resistance at our hospitals.

Methods

This retrospective study involved 160 patients on low-dose bisphosphonates (BPs) requiring tooth extractions between 2019 and 2024 at four Japanese institutions. In 2019–2021, patients received amoxicillin (AMPC) 500 mg 1 h before and 750 mg per day for 2 days post-extraction. In 2022–2024, a single 500 mg dose of AMPC was administered 1 h pre-extraction. Patients were managed with tension-free wound suturing and regular follow-up. The rates of MRONJ development were compared between the two periods.

Results

MRONJ developed in 3 out of 170 teeth (1.76%) in 2019–2021, and in 2 out of 147 teeth (1.36%) in 2022–2024, with no significant difference (P = 1.000). All MRONJ cases were low-stage (Stage 1) and healed completely within 12–16 weeks. Four out of five MRONJ cases (80%) exhibited radiopaque changes around the root. When all teeth in both groups were surveyed, MRONJ development was significantly higher in teeth with such changes compared to those without (4/58 vs. 1/259; P = 0.004).

Conclusion

A single preoperative dose of AMPC may be sufficient for tooth extractions in patients on low-dose BPs. However, teeth with radiopaque changes around the root require careful monitoring postextraction.